pfm medical has developed an ultra-light mesh implant, TiLOOP® Bra, to support tissue and implants in oncoplastic and reconstructive breast surgery. The mesh, which is 100% biocompatible, is made from a patented composite material with a covalently bonded titanium surface. The results of the study Implant-Based Breast Reconstruction Using a Titanium-Coated Polypropylene Mesh (TiLOOP® Bra): A Multicenter Study of 231 Cases have now been published by M. Dieterich et al. in the most recent edition of Plastic & Reconstructive Surgery®, the journal of the American Society of Plastic Surgeons. The primary goal of the study was to identify patient-related and surgical risk factors so that well-founded recommendations can be made for breast reconstruction with TiLOOP® Bra. The secondary goal of the study was to record the complication rate during the study period.With 183 patients (231 breasts) the study is the largest so far to evaluate treatment with TiLOOP® Bra. The results of the analysis show that TiLOOP® Bra facilitated implant-aided instant reconstruction in the patients selected. No patient-related risk factors were identified in relation to primary breast reconstruction with the TiLOOP® Bra implant. Overall the study confirms the positive findings for the mesh implant’s properties which include low rates of inflammation and rapid ingrowth into the surrounding tissue. Breast reconstruction with TiLOOP® Bra is therefore a safe form of treatment.Three different versions of TiLOOP® Bra are available to support smaller (< 200 g), medium (< 350 g) and larger (< 500 g) breast sizes. pfm medical’s titanised meshes can also be used in other areas including hernia surgery and pelvic floor surgery. They are produced by pfm medical titanium gmbh, a pfm medical company based in Nuremberg, Germany.
↧